
Organization · Accelerator
CO-AX Accelerator at Sahlgrenska Science Park
CO-AX Accelerator at Sahlgrenska Science Park is a leading incubator and accelerator in Gothenburg, Sweden, focused on supporting early-stage health-tech, medtech, and life science startups. It aims to help startups navigate challenges like regulatory requirements and market access.
Overview
What CO-AX Accelerator at Sahlgrenska Science Park does
What CO-AX Accelerator at Sahlgrenska Science Park is
CO-AX Accelerator at Sahlgrenska Science Park is a leading incubator and accelerator in Gothenburg, Sweden, focused on supporting early-stage health-tech, medtech, and life science startups. It aims to help startups navigate challenges like regulatory requirements and market access.
How it participates in the startup ecosystem
The current public profile supports funder and program host capabilities. Each capability below is shown separately so organization identity and role-specific information do not get conflated.
Operational profile
Organization status and context
Organization status describes the entity itself. Funding and program availability appear within the relevant capability profile.
- Operational status
- Active
- Organization type
- Accelerator
- Structured capabilities
- Funder · Program host
- Last reviewed
- April 6, 2026
What Accelerator means
An accelerator is a structured, short-term program designed to speed up a startup's progress toward product-market fit, traction, fundraising, or scale.
Open the glossary entryOfficial channels
Find CO-AX Accelerator at Sahlgrenska Science Park elsewhere
Open the official website or a supported primary organization account.
Capability profile
CO-AX Accelerator at Sahlgrenska Science Park as a funder
Investment thesis
CO-AX Accelerator supports health tech startups by providing resources and expertise to tackle global health challenges.
Focus narrative
CO-AX Accelerator invests in health tech, medtech, biotech, and deep tech startups. It supports companies at various stages, from early entrepreneurship and pre-incubation to tailored incubation and global commercialization. The organization emphasizes innovation that addresses unmet needs in global healthcare, particularly in the areas of patient care and medical diagnostics.
Value beyond capital
CO-AX Accelerator adds value to portfolio companies through tailored coaching, market access opportunities, regulatory guidance, and networking with healthcare professionals and industry experts.
Focus and fit
- Stages
- Pre-seed · Seed · Seed+ · Series A · Series B · Series C · Growth Equity
- Regions
- Europe
Availability
- Currently deploying
- Yes
Portfolio and track record
- Recorded portfolio count
- 150
Portfolio context
CO-AX Accelerator has incubated over 150 startups, which have collectively raised significant capital, amounting to 7.5 billion SEK. Notable portfolio companies include Detectivio, which develops AI-powered technology for contactless health measurements; VSA Innovation, focusing on AI-driven automated urine testing and analysis; Nanocept, engaging in nanotechnology applications; CSW, working on treating heart disease using sound technology; LifeAtlas, providing tools for personal health management; BrainLink, specializing in the diagnosis and treatment of hydrocephalus; RegxitTech, offering AI solutions for efficiency in healthcare; Black, developing nanotechnology for dental applications; and Elevyo, providing deep health insights and real-life results.
Capability profile
CO-AX Accelerator at Sahlgrenska Science Park as a program host
Program thesis
CO-AX Accelerator supports health tech startups to tackle global health challenges by providing resources and expertise to scale their solutions.
Focus narrative
CO-AX Accelerator invests in health tech, medtech, biotech, and deep tech startups. It supports companies at various stages, from early entrepreneurship and pre-incubation to tailored incubation and global commercialization, emphasizing innovation that addresses unmet needs in global healthcare.
Value and support
CO-AX Accelerator offers tailored coaching, market access opportunities, regulatory guidance, and networking opportunities with healthcare professionals and events.
Availability
- Application state
- Accepting
Focus and fit
- Stages
- Pre-seed · Seed
- Regions
- Europe
Alumni and track record
Alumni context
Notable portfolio companies include Detectivio, which develops AI-powered technology for contactless health measurements; VSA Innovation, focusing on AI-driven automated urine testing; Nanocept, engaged in nanotechnology applications; and CSW, which works on treating heart disease using sound technology.
Connected ecosystem
Continue from CO-AX Accelerator at Sahlgrenska Science Park
These links use structured organization type, sector, and regional relationships. They do not imply endorsement or commercial similarity.
Same organization type
Structured sector focus
Structured regional focus
Common questions
What to know about CO-AX Accelerator at Sahlgrenska Science Park
Upseed classifies CO-AX Accelerator at Sahlgrenska Science Park under the Accelerator organization type. Its current public profile includes funder and program host capabilities.
Source and update disclosure
Know what this page is based on
Source basis
Public organization and program material, official websites, and structured Upseed records.
Last reviewed
April 6, 2026
Known limits
Capability profiles appear only when a structured public profile also contains decision-useful role evidence. Terms and availability can change.
Upseed is an independent guide. It is not affiliated with or endorsed by the organization described on this page.